Synthetic Biologics, Inc (SYN)
(Delayed Data from AMEX)
$0.64 USD
+0.04 (5.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $0.64 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.64 USD
+0.04 (5.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $0.64 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
New Trends in Healthcare Push Stocks Higher: 5 Picks
by Zacks Equity Research
New healthcare trends backed by split party control of Congress are likely to boost industry stocks.
Synthetic Biologics (SYN) in Focus: Stock Moves 7.7% Higher
by Zacks Equity Research
Synthetic Biologics (SYN) was a big mover last session, as the company saw its shares rise nearly 8% on Friday amid huge volumes.
Can The Uptrend Continue for Synthetic Biologics (SYN)?
by Zacks Equity Research
Investors certainly have to be happy with Synthetic Biologics Inc (SYN) and its short term performance
Forget Gilead, Buy These Small-Cap Biotech Stocks Instead
by Zacks Equity Research
At this juncture, we advise investors to forget Gilead (GILD), a Zacks Rank #4 (Sell) stock, and invest in some other small cap biotech stocks (market capitalization below $200 million) that carry an impressive Zacks Rank.